BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19209159)

  • 1. Why postprandial abdominal bloating in patients with irritable bowel syndrome does not respond to prokinetics.
    Bortolotti M; Lugli A
    Am J Gastroenterol; 2009 Mar; 104(3):794. PubMed ID: 19209159
    [No Abstract]   [Full Text] [Related]  

  • 2. Bloating and abdominal distention: not so poorly understood anymore!
    Simrén M
    Gastroenterology; 2009 May; 136(5):1487-90. PubMed ID: 19327731
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the origin of postprandial abdominal distension in patients with functional bloating and irritable bowel syndrome?
    Bortolotti M; Lugli A
    Scand J Gastroenterol; 2009; 44(3):383-4. PubMed ID: 19085209
    [No Abstract]   [Full Text] [Related]  

  • 4. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meteospazmil for correction of motor disorders in functional colon diseases].
    Agafonova NA; Iakovenko EP; Ivanov AN; Prianishnikova AS; Iakovenko AV
    Eksp Klin Gastroenterol; 2009; (4):101-6. PubMed ID: 19961001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intestinal motility disorders and visceral hypersensitivity in irritable bowel syndrome].
    Ropert A; Bouguen G
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S35-9. PubMed ID: 19303537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Irritable bowel syndrome: modern ideas, vexed and unsolved problems].
    Tsimmerman IaS
    Eksp Klin Gastroenterol; 2003; (6):124-32. PubMed ID: 15065542
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment experience of patients with irritable bowel syndrome complicated by constipations with medicinal preparation softovak].
    Ruchkina IN; Lychkova AE; Parfenov AI
    Eksp Klin Gastroenterol; 2007; (5):103-6. PubMed ID: 18389606
    [No Abstract]   [Full Text] [Related]  

  • 10. [Irritable bowel syndrome: issues of diagnosis and treatment efficiency].
    Loranskaia ID
    Eksp Klin Gastroenterol; 2008; (1):90-5. PubMed ID: 19145859
    [No Abstract]   [Full Text] [Related]  

  • 11. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
    Sinagra E; Morreale GC; Mohammadian G; Fusco G; Guarnotta V; Tomasello G; Cappello F; Rossi F; Amvrosiadis G; Raimondo D
    World J Gastroenterol; 2017 Sep; 23(36):6593-6627. PubMed ID: 29085207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms.
    Agrawal A; Whorwell PJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):2-10. PubMed ID: 17931344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.
    Camilleri M
    Gastroenterology; 2021 Sep; 161(3):761-764. PubMed ID: 33989661
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatments targeting putative mechanisms in irritable bowel syndrome.
    Cremonini F; Talley NJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):82-8. PubMed ID: 16265125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of irritable bowel syndrome and an update on therapeutic approaches.
    Bassett JT; Cash BD
    Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for irritable bowel syndrome.
    Harmon HW
    Nurse Pract; 2007 Jul; 32(7):39-43. PubMed ID: 17595589
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging drugs for irritable bowel syndrome.
    Shekhar C; Whorwell PJ
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):673-85. PubMed ID: 19939211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome and bloating.
    Hasler WL
    Best Pract Res Clin Gastroenterol; 2007; 21(4):689-707. PubMed ID: 17643909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By the way, doctor. I have irritable bowel syndrome, with frequent bloating and constipation. My doctor prescribed a six-week course of Zelnorm, which really helped. Is it safe to take long-term?
    Robb-Nicholson C
    Harv Womens Health Watch; 2005 May; 12(9):8. PubMed ID: 16047399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.